Discover
JAMA Pediatrics Author Interviews
Nusinersen for Spinal Muscular Atrophy: Ensuring Equity at High Cost

Nusinersen for Spinal Muscular Atrophy: Ensuring Equity at High Cost
Update: 2017-12-11
Share
Description
Interview with Alyssa Burgart, MD, MA, author of Ethical Challenges Confronted When Providing Nusinersen Treatment for Spinal Muscular Atrophy, and Vinay Prasad, author of Nusinersen for Spinal Muscular Atrophy: Are We Paying Too Much for Too Little?
Comments
In Channel






















